Deutsche Bank’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $918M | Buy |
7,269,170
+1,046,842
| +17% | +$138M | 0.27% | 77 |
|
|
2026
Q1 | $867M | Buy |
6,222,328
+28,574
| +0.5% | +$4M | 0.29% | 71 |
|
|
2025
Q4 | $760M | Sell |
6,193,754
-2,761,535
| -31% | -$336M | 0.25% | 86 |
|
|
2025
Q3 | $994M | Buy |
8,955,289
+2,774,250
| +45% | +$315M | 0.33% | 53 |
|
|
2025
Q2 | $685M | Sell |
6,181,039
-485,213
| -7% | -$51.6M | 0.25% | 79 |
|
|
2025
Q1 | $747M | Sell |
6,666,252
-870,546
| -12% | -$89.8M | 0.3% | 66 |
|
|
2024
Q4 | $696M | Sell |
7,536,798
-992,259
| -12% | -$89.3M | 0.27% | 69 |
|
|
2024
Q3 | $715M | Buy |
8,529,057
+1,322,055
| +18% | +$101M | 0.29% | 72 |
|
|
2024
Q2 | $494M | Sell |
7,207,002
-293,366
| -4% | -$19.6M | 0.22% | 89 |
|
|
2024
Q1 | $549M | Sell |
7,500,368
-191,049
| -2% | -$14.7M | 0.26% | 82 |
|
|
2023
Q4 | $623M | Buy |
7,691,417
+725,825
| +10% | +$56.5M | 0.32% | 68 |
|
|
2023
Q3 | $522M | Sell |
6,965,592
-1,167,311
| -14% | -$89.8M | 0.34% | 61 |
|
|
2023
Q2 | $627M | Sell |
8,132,903
-1,068,098
| -12% | -$85.2M | 0.33% | 64 |
|
|
2023
Q1 | $763M | Buy |
9,201,001
+821,730
| +10% | +$68.1M | 0.43% | 50 |
|
|
2022
Q4 | $719M | Sell |
8,379,271
-226,993
| -3% | -$18M | 0.41% | 51 |
|
|
2022
Q3 | $531M | Sell |
8,606,264
-344,082
| -4% | -$21.7M | 0.32% | 71 |
|
|
2022
Q2 | $553M | Buy |
8,950,346
+746,049
| +9% | +$46.2M | 0.31% | 72 |
|
|
2022
Q1 | $488M | Buy |
8,204,297
+656,020
| +9% | +$41.9M | 0.23% | 100 |
|
|
2021
Q4 | $548M | Sell |
7,548,277
-30,077
| -0.4% | -$2.07M | 0.25% | 88 |
|
|
2021
Q3 | $529M | Sell |
7,578,354
-415,349
| -5% | -$29.2M | 0.25% | 87 |
|
|
2021
Q2 | $550M | Buy |
7,993,703
+282,231
| +4% | +$18.8M | 0.27% | 81 |
|
|
2021
Q1 | $498M | Buy |
7,711,472
+464,519
| +6% | +$30M | 0.27% | 74 |
|
|
2020
Q4 | $422M | Sell |
7,246,953
-258,256
| -3% | -$15.6M | 0.26% | 82 |
|
|
2020
Q3 | $474M | Buy |
7,505,209
+245,583
| +3% | +$17M | 0.33% | 60 |
|
|
2020
Q2 | $559M | Sell |
7,259,626
-695,463
| -9% | -$53.3M | 0.42% | 40 |
|
|
2020
Q1 | $595M | Sell |
7,955,089
-2,749,763
| -26% | -$190M | 0.53% | 37 |
|
|
2019
Q4 | $696M | Sell |
10,704,852
-112,043
| -1% | -$7.3M | 0.45% | 41 |
|
|
2019
Q3 | $686M | Sell |
10,816,895
-998,511
| -8% | -$65.3M | 0.48% | 41 |
|
|
2019
Q2 | $798M | Sell |
11,815,406
-728,819
| -6% | -$47.9M | 0.47% | 40 |
|
|
2019
Q1 | $815M | Buy |
12,544,225
+1,195,589
| +11% | +$79.5M | 0.49% | 34 |
|
|
2018
Q4 | $710M | Sell |
11,348,636
-1,022,538
| -8% | -$71.5M | 0.5% | 36 |
|
|
2018
Q3 | $955M | Buy |
12,371,174
+1,152,358
| +10% | +$87M | 0.48% | 34 |
|
|
2018
Q2 | $795M | Sell |
11,218,816
-1,193,188
| -10% | -$84.3M | 0.4% | 43 |
|
|
2018
Q1 | $936M | Buy |
12,412,004
+1,858,266
| +18% | +$148M | 0.45% | 41 |
|
|
2017
Q4 | $756M | Sell |
10,553,738
-283,466
| -3% | -$21.5M | 0.48% | 33 |
|
|
2017
Q3 | $878M | Sell |
10,837,204
-1,122,899
| -9% | -$85.9M | 0.6% | 22 |
|
|
2017
Q2 | $847M | Sell |
11,960,103
-230,289
| -2% | -$15.3M | 0.6% | 23 |
|
|
2017
Q1 | $828M | Buy |
12,190,392
+1,178,365
| +11% | +$82.9M | 0.61% | 23 |
|
|
2016
Q4 | $789M | Buy |
11,012,027
+359,635
| +3% | +$26.7M | 0.63% | 19 |
|
|
2016
Q3 | $843M | Buy |
10,652,392
+231,552
| +2% | +$18.8M | 0.6% | 28 |
|
|
2016
Q2 | $869M | Sell |
10,420,840
-48,639
| -0.5% | -$4.32M | 0.61% | 24 |
|
|
2016
Q1 | $962M | Sell |
10,469,479
-1,009,868
| -9% | -$91.1M | 0.72% | 15 |
|
|
2015
Q4 | $1.16B | Buy |
11,479,347
+2,387,177
| +26% | +$248M | 0.8% | 10 |
|
|
2015
Q3 | $893M | Sell |
9,092,170
-634,798
| -7% | -$70.5M | 0.69% | 12 |
|
|
2015
Q2 | $1.14B | Sell |
9,726,968
-1,646,234
| -14% | -$180M | 0.73% | 12 |
|
|
2015
Q1 | $1.12B | Buy |
11,373,202
+1,989,852
| +21% | +$202M | 0.69% | 13 |
|
|
2014
Q4 | $884M | Buy |
9,383,350
+1,203,957
| +15% | +$125M | 0.55% | 23 |
|
|
2014
Q3 | $871M | Sell |
8,179,393
-1,233,057
| -13% | -$121M | 0.54% | 28 |
|
|
2014
Q2 | $780M | Buy |
9,412,450
+1,221,998
| +15% | +$95.1M | 0.53% | 23 |
|
|
2014
Q1 | $580M | Sell |
8,190,452
-1,176,514
| -13% | -$92.3M | 0.41% | 38 |
|
|
2013
Q4 | $703M | Sell |
9,366,966
-5,337,104
| -36% | -$372M | 0.51% | 27 |
|
|
2013
Q3 | $924M | Buy |
14,704,070
+2,523,936
| +21% | +$151M | 0.68% | 17 |
|
|
2013
Q2 | $624M | Buy |
+12,180,134
| New | +$635M | 0.51% | 28 |
|
Other funds holding GILD
Deutsche Bank's GILD Position: Q2 2026 in Review
Deutsche Bank increased its Gilead Sciences (GILD) stake by 17% in Q2 2026, buying an estimated $138M and bringing the position to 7,269,170 shares worth $918M. The position accounts for 0.27% of the portfolio, ranked #77.
Deutsche Bank first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.16B in Q4 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Deutsche Bank held 7,269,170 shares of Gilead Sciences worth $918M as of Q2 2026.
- Deutsche Bank bought 1,046,842 Gilead Sciences shares in Q2 2026, an estimated $138M.
- Gilead Sciences made up 0.27% of Deutsche Bank's portfolio in Q2 2026, its #77 holding.
- Deutsche Bank first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Deutsche Bank's Gilead Sciences position peaked at $1.16B in Q4 2015.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.